| Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients | ULUHAN SİLİ,Aysun TEKİN,VOLKAN KORTEN | 39–42 |
| Can Detection of Non-alcoholic Fatty Liver Disease be Coincidental in Young Patients with Chronic Hepatitis B? | Zehra KARACAER,Gokcan OKUR,ALİ HAKAN ÇERMİK,Özgür AVCI | 43–47 |
| The Frequency of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus Infections among Patients with Schizophrenia in a Mental Health Hospital in Turkey | Nuran KARABULUT | 48–51 |
| Red Cell Volume Distribution Width to Platelet Ratio is an Important Predictor of Liver Fibrosis and Cirrhosis in Chronic Hepatitis B | İSMAİL NECATİ HAKYEMEZ,Sibel BÖLÜKÇÜ,BÜLENT DURDU,TURAN ASLAN | 52–57 |
| Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic | Zehra BEŞTEPE DURSUN,İlhami ÇELİK | 58–61 |
| Seroprevalence of Hepatitis B Virus, Hepatitis C Virus and HIV among Health Care Staff in a State Hospital | HANDAN ALAY,Neslihan ÇELİK,BERRİN GÖKTUĞ KADIOĞLU,ESRA ÇINAR TANRIVERDİ,Emine PARLAK,Fatma MUTLUBATTAL,Zülal ÖZKURT | 62–64 |
| Seroprevalence of Hepatitis B Virus, Hepatitis C Virus and HIV among Health Care Staff in a State Hospital | Handan ALAY, Esra TANRIVERDİ ÇINAR, Berrin KADIOĞLU GÖKTUĞ, Neslihan ÇELİK, Emine PARLAK, Fatma MUTLUBATTAL, Zülal ÖZKURT | 62–64 |
| Seroprevalence Rates of Hepatitis B Surface Antigen, AntiHepatitis C Virus and Anti-Human Immunodeficiency Virus ½ Certain Risk Groups | Tayfur DEMİRAY,KEREM CAN YILMAZ,MEHMET KÖROĞLU,Mustafa ALTINDİŞ | 65–66 |
| Seroprevalence Rates of Hepatitis B Surface Antigen, AntiHepatitis C Virus and Anti-Human Immunodeficiency Virus ½ Certain Risk Groups | Mehmet KÖROĞLU, Kerem YILMAZ, Mustafa ALTINDİŞ, Tayfur DEMİRAY | 65–66 |
| Liver Biopsy is the Gold Standard at Present, How about Tomorrow? | Murat AFYON | 67–68 |
| Liver Biopsy is the Gold Standard at Present, How about Tomorrow? | Murat AFYON | 67–68 |